Research and Clinical Trials

Title  
Phase 3 Study of ADXS11-001 Administered Following Chemoradiation as Adjuvant Treatment for High Risk Locally Advanced Cervical Cancer: AIM2CERV
Brief Description  
Progression free survival
Who may be Eligible  
Please contact us for eligibility criteria.
Speciality/Disorder  
Cervix
Status  
OPEN
Start Date  
05/08/2017
IRB Number  
00019144
Principal Investigator  
Crane, Erin King
Contact Name  
Heather N Neagle

For More Information, Contact  Heather  N, Neagle
Phone:  980-442-2303 Fax:    
Email:  heather.neagle@carolinashealthcare.org
Address:1021 Morehead Medical Drive Suite 2200 Charlotte, 28204
Close